Skip to content

ISSN: 1792-7110

HAEMA

The Journal of the Hellenic Society of HAEMATOLOGY

HOME
ABOUT
- JOURNAL INFORMATION
- EDITORIAL BOARD
CURRENT ISSUE
AUTHORS
ARCHIVE
SUBMIT YOUR MANUSCRIPT
CONTACT US

Category: HAEMA 2010 (4)

21st Panhellenic Hematological Congress

Posted on June 26, 2018June 26, 2018 by admin

Haema 2010; 1(4)

CONGRESS PROCEEDINGS

Full PDF (in Greek) |

Posted in HAEMA 2010 (4)

SEARCH

CURRENT ISSUE

Prognostic Significance of IDH1 and IDH2 Mutations in Greek Patients with Newly Diagnosed AML

The Role of Venetoclax in the Treatment of Acute Myeloid Leukemia

Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies

Differential Diagnosis of Thrombotic Microangiopathies: From Bench to Bedside

Comment on: Bitsani et al “Prognostic Significance of IDH1 and IDH2 Mutations in Newly Diagnosed AML Patients in Greece”

A hot dark skeleton

About Us

HAEMA is the official journal of the Hellenic Society of Hematology. HAEMA was founded in March 1998, since when it has been published regularly and has undergone several modifications,in both the language (Greek-English) and the content of the journal.
The new edition of HAEMA is an English language, independent, open-access, peer reviewed journal, published quarterly.
FIND ARTICLE BY KEYWORD

5 years (1) Acute lymphoblastic leukemia (1) Acute myeloid leukemia (1) ALL (1) AML (1) Anemia (1) Anti-GDF11 drugs (1) BCR-JAK2 (1) Biochemical biomarkers (1) Blinatumomab (1) CAR-T cells (1) CD71 (1) Chemotherapy (1) Clinical trials (1) Complement inhibitors (1) Diagnosis (1) DLBCL (1) HELLP syndrome (1) Hematological (1) Hemolytic uremic syndrome (1) Hodgkin lymphoma (1) IDH1/IDH2 mutations (1) Inotuzumab ozogamicin (1) Iron overload (1) JAK2 (1) Mechanism of action (1) Mixed cellularity (1) Multiple myeloma (1) PET-CT (1) Ph-like ALL (1) Philadelphia-chromosome positive ALL (1) Prognosis (1) Radiotherapy (1) Relapse (1) Ruxolitinib (1) sTfR (1) Thrombotic microangiopathy (1) Thrombotic thrombocytopenic purpura (1) Transfusion related reactions (1) Transplant-associated thrombotic microangiopathy (1) Treatment (1) TRRC1 (1) Tyrosine-kinase inhibitors (1) Venetoclax (1) very late (1)

Theme by Out the Box